José Palacios Selected Research

Immunotherapy

1/2021	Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB2 harmonization project comparing three NGS panels.
8/2020	Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications.
1/2020	Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.
1/2019	Efficacy of immunotherapy in sarcomatoid lung cancer, a case report and literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Palacios Research Topics

Disease

70	Neoplasms (Cancer) 07/2023 - 01/2002
50	Breast Neoplasms (Breast Cancer) 05/2024 - 05/2002
27	Carcinoma (Carcinomatosis) 07/2023 - 04/2003
17	Endometrial Neoplasms (Endometrial Cancer) 07/2020 - 11/2002
13	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2004
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 12/2004
5	Adenocarcinoma 01/2014 - 09/2006
5	Microsatellite Instability 10/2005 - 08/2003
4	Lobular Carcinoma 05/2024 - 07/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 05/2013
4	Carcinosarcoma 02/2014 - 02/2008
4	Carcinogenesis 07/2006 - 09/2003
3	Hyperplasia 05/2024 - 04/2003
3	COVID-19 01/2022 - 01/2021
3	Endometrioid Carcinoma 01/2020 - 09/2003
3	Lymphatic Metastasis 08/2016 - 04/2003
3	Ductal Carcinoma 08/2014 - 07/2003
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2004
2	Turcot syndrome 01/2021 - 08/2020
2	Disease Progression 01/2021 - 01/2020
2	Metaplasia 01/2020 - 10/2005
2	Ovarian Epithelial Carcinoma 01/2020 - 04/2018
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2013 - 09/2011
1	Inflammation (Inflammations) 10/2022
1	Macrophage Activation Syndrome 10/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Infections 01/2022
1	Mediastinitis 01/2022
1	Atrioventricular Block 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Pilomatrixoma 09/2021
1	Triple Negative Breast Neoplasms 07/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Necrosis 01/2020
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2020
1	Primitive Neuroectodermal Tumors (PNET) 01/2020

Drug/Important Bio-Agent (IBA)

18	Cadherins (E-Cadherin)IBA 05/2024 - 05/2002
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2003
11	CateninsIBA 11/2022 - 05/2002
11	Estrogen ReceptorsIBA 09/2021 - 10/2005
11	beta CateninIBA 09/2021 - 11/2002
10	Biomarkers (Surrogate Marker)IBA 03/2023 - 05/2009
7	MicroRNAs (MicroRNA)IBA 08/2014 - 01/2011
6	ErbB Receptors (EGF Receptor)IBA 01/2021 - 10/2004
6	Phenobarbital (Luminal)FDA Link 06/2020 - 12/2008
6	ParaffinIBA 12/2014 - 10/2004
5	Messenger RNA (mRNA)IBA 03/2023 - 09/2011
5	Progesterone Receptors (Progesterone Receptor)IBA 09/2021 - 10/2005
5	Hormones (Hormone)IBA 06/2020 - 09/2003
5	Estrogens (Estrogen)FDA Link 06/2015 - 09/2003
5	Cyclin D1IBA 04/2009 - 09/2003
4	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 11/2003
4	Exonucleases (3' 5' Exonuclease)IBA 01/2020 - 01/2016
4	Keratins (Keratin)IBA 08/2018 - 07/2004
4	Complementary DNA (cDNA)IBA 02/2013 - 09/2003
4	Fluorouracil (Carac)FDA LinkGeneric 06/2008 - 10/2004
4	Paclitaxel (Taxol)FDA LinkGeneric 06/2008 - 04/2007
4	gamma Catenin (Plakoglobin)IBA 08/2006 - 11/2002
3	CyclinsIBA 01/2023 - 03/2005
3	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2003
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 09/2011
3	Taxoids (Taxanes)IBA 11/2017 - 04/2007
3	Keratin-5 (Keratin 5)IBA 09/2007 - 03/2006
3	NucleosidesIBA 04/2007 - 12/2004
2	osteoblast cadherinIBA 01/2022 - 08/2006
2	Protein Isoforms (Isoforms)IBA 01/2022 - 12/2004
2	Calcibiotic Root Canal SealerIBA 01/2021 - 07/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2004
2	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 11/2016 - 01/2016
2	Co-Repressor ProteinsIBA 11/2016 - 01/2016
2	Tamoxifen FDA LinkGeneric 03/2014 - 08/2008
2	OsteonectinIBA 11/2013 - 04/2007
2	CannabinoidsIBA 07/2010 - 07/2006
2	Laminin (Merosin)IBA 02/2008 - 09/2007
2	fascinIBA 02/2008 - 03/2006
2	NF-kappa B (NF-kB)IBA 04/2007 - 12/2004
2	Cell Cycle ProteinsIBA 10/2005 - 03/2005
2	Delta CateninIBA 04/2004 - 04/2003
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	GasderminsIBA 01/2022
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2022
1	CollagenIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	ferrous sulfate FDA Link 01/2022
1	B7-H1 AntigenIBA 07/2021
1	human ERBB2 proteinIBA 06/2020
1	palbociclibIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	NanocapsulesIBA 01/2019

Therapy/Procedure

15	Therapeutics 01/2022 - 07/2006
10	Drug Therapy (Chemotherapy) 07/2023 - 10/2004
4	Immunotherapy 01/2021 - 01/2019
2	Precision Medicine 07/2018 - 11/2017
2	Neoadjuvant Therapy 11/2017 - 08/2016
2	Adjuvant Chemotherapy 12/2014 - 09/2007
1	Tracheostomy 01/2022
1	Length of Stay 01/2021